Hip Joint Injection

Excerpt

Hip pain is a common clinical complaint and a source of disability with an incidence of 12 to 15 percent among all adults over the age of 60 years. Radiographic hip osteoarthritis affects 27% of adults above the age of 45 years. A lifetime risk of 25% is seen in those who are older than 85 years of age and with a 10% lifetime risk for eventual total hip replacement. Osteoarthritis of the hip involves a progressive loss of articular cartilage. Subchondral cysts, osteophyte formation, and synovial inflammation can subsequently develop. Therapeutic hip joint injection with corticosteroids, hyaluronic acid, and plasma-rich platelets have formed the cornerstone of non-surgical management of hip pain.

The important aspects of a fluoroscopic guided hip joint injection include:

1. Minimize patient discomfort

2. Maintain patient safety

3. Maintain proper needle technique in accessing the intraarticular joint space